InvestorsHub Logo
Followers 8
Posts 1167
Boards Moderated 1
Alias Born 01/07/2008

Re: None

Friday, 06/26/2009 12:18:52 PM

Friday, June 26, 2009 12:18:52 PM

Post# of 18493
Perhaps I should know this, but is this their wholly owned subsidiary?

SynGen Inc.
Private Subsidiary, Headquarters Location
384 Foster City Blvd., Foster City, CA 94404-1105, United States
(650)212-0000, (650)212-0011 fax, http://www.syngendna.com
Primary SIC: Laboratory Analytical Instruments, Primary NAICS: Analytical Laboratory Instrument Manufacturing
Description: Manufacturing: Services: Developer of blood purification technology.


From Aethlon Medical the board of directors list:

"Richard H. Tullis, Ph.D. - Vice President, Chief Science Officer
Dr. Tullis has extensive biotechnology management and research experience, and is the founder of Syngen Research, a wholly-owned subsidiary of Aethlon Medical, Inc. Dr. Tullis became a Vice President and Director of Aethlon Medical, Inc. in January of 2000, and succeeded Dr. Clara M. Ambrus as Chief Scientific Officer in June of 2001. Previously, Dr. Tullis co-founded Molecular Biosystems, Inc., a former NYSE company. At Molecular Biosystems, Dr. Tullis was Director of Research and Development, Director of Oligonucleotide Hybridization, Senior Research Scientist and Member of the Board of Directors. In research, Dr. Tullis developed and patented the first application of oligonucleotides to antisense antibiotics and developed new methods for the chemical synthesis of DNA via methoxy-phosphorochloridites. Dr. Tullis also co-developed the first applications of covalently coupled DNA-enzyme conjugates using synthetic oligonucleotides during his tenure at Molecular Biosystems. In 1985, Dr. Tullis founded, and served as President and CEO of Synthetic Genetics, Inc., a pioneer in custom DNA synthesis, which was sold to Molecular Biology Resources in 1991. Dr. Tullis also served as interim-CEO of Genetic Vectors, Inc., which completed its IPO under his management, and was co-founder of DNA Sciences, Inc., a company that was eventually acquired by Genetic Vectors. Dr Tullis received his Ph.D. in Biochemistry and Cell Biology from the University of California at San Diego, and has done extensive post-doctoral work at UCSD, USC, and The Scripps Research Institute.
"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News